JP2024525794A - 新生児の治療におけるラクトバチルス・パラカゼイ（Ｌａｃｔｏｂａｃｉｌｌｕｓ ｐａｒａｃａｓｅｉ）菌株の使用 - Google Patents

新生児の治療におけるラクトバチルス・パラカゼイ（Ｌａｃｔｏｂａｃｉｌｌｕｓ ｐａｒａｃａｓｅｉ）菌株の使用 Download PDF

Info

Publication number
JP2024525794A
JP2024525794A JP2024502018A JP2024502018A JP2024525794A JP 2024525794 A JP2024525794 A JP 2024525794A JP 2024502018 A JP2024502018 A JP 2024502018A JP 2024502018 A JP2024502018 A JP 2024502018A JP 2024525794 A JP2024525794 A JP 2024525794A
Authority
JP
Japan
Prior art keywords
strain
group
lactobacillus paracasei
treatment
dsm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024502018A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024525794A5 (https=
JPWO2023286027A5 (https=
Inventor
アンドレア ビッフィ，
ウォルター フィオーレ，
Original Assignee
アルファシグマ ソシエタ ペル アチオニ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アルファシグマ ソシエタ ペル アチオニ filed Critical アルファシグマ ソシエタ ペル アチオニ
Publication of JP2024525794A publication Critical patent/JP2024525794A/ja
Publication of JP2024525794A5 publication Critical patent/JP2024525794A5/ja
Publication of JPWO2023286027A5 publication Critical patent/JPWO2023286027A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2024502018A 2021-07-15 2022-07-15 新生児の治療におけるラクトバチルス・パラカゼイ（Ｌａｃｔｏｂａｃｉｌｌｕｓ ｐａｒａｃａｓｅｉ）菌株の使用 Pending JP2024525794A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT102021000018740 2021-07-15
IT102021000018740A IT202100018740A1 (it) 2021-07-15 2021-07-15 Uso di ceppi di batteri Lactobacillus paracasei nel trattamento di neonati
PCT/IB2022/056538 WO2023286027A1 (en) 2021-07-15 2022-07-15 Use of lactobacillus paracasei bacterial strains in the treatment of newborns

Publications (3)

Publication Number Publication Date
JP2024525794A true JP2024525794A (ja) 2024-07-12
JP2024525794A5 JP2024525794A5 (https=) 2025-07-08
JPWO2023286027A5 JPWO2023286027A5 (https=) 2025-07-08

Family

ID=78212428

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024502018A Pending JP2024525794A (ja) 2021-07-15 2022-07-15 新生児の治療におけるラクトバチルス・パラカゼイ（Ｌａｃｔｏｂａｃｉｌｌｕｓ ｐａｒａｃａｓｅｉ）菌株の使用

Country Status (11)

Country Link
US (1) US20240350567A1 (https=)
EP (1) EP4370142A1 (https=)
JP (1) JP2024525794A (https=)
KR (1) KR20240038015A (https=)
CN (1) CN119365205A (https=)
AU (1) AU2022312760A1 (https=)
CA (1) CA3222905A1 (https=)
IL (1) IL309883A (https=)
IT (1) IT202100018740A1 (https=)
MX (1) MX2024000520A (https=)
WO (1) WO2023286027A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118813489A (zh) * 2024-08-29 2024-10-22 北京科拓恒通生物技术股份有限公司 一种用于缓解便秘和腹泻的益生菌后生元和制备方法及其用途
CN120361059A (zh) * 2025-06-30 2025-07-25 天津创源生物技术有限公司 一种副干酪乳酪杆菌iob413后生元在胃食管反流上的应用
CN121533530A (zh) * 2026-01-19 2026-02-17 内蒙古农业大学 一种副干酪乳酪杆菌-复合益生元复配制剂、制备方法及其应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012526529A (ja) * 2009-05-11 2012-11-01 ネステク ソシエテ アノニム プロバイオティクス微生物を含む乳幼児用補給調製乳
WO2021053636A1 (en) * 2019-09-20 2021-03-25 Sofar S.P.A. Bacterial strains, their compositions and their use for the treatment of gastrointestinal disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201900000801A1 (it) * 2019-01-18 2020-07-18 Proge Farm Srl Composizione comprendente batteri probiotici non vitali e suo uso in terapia
IT201900016865A1 (it) * 2019-09-20 2021-03-20 Sofar Spa Composizioni a base di ceppi batterici e loro uso come antinfiammatori
IT201900020422A1 (it) * 2019-11-05 2021-05-05 Sofar Spa Composizioni comprendenti ceppi di batteri per uso per aumentare la biodisponibilità degli amminoacidi derivanti da proteine
IT202000012448A1 (it) * 2020-05-26 2021-11-26 Sofar Spa Composizioni comprendenti un derivato della cannabis sativa e ceppi di batteri e loro uso terapeutico
IT202100008300A1 (it) * 2021-04-01 2022-10-01 Bll Invest S R L Ceppi di batteri inattivati, quali batteri vitali ma non coltivabili, loro composizioni e loro uso

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012526529A (ja) * 2009-05-11 2012-11-01 ネステク ソシエテ アノニム プロバイオティクス微生物を含む乳幼児用補給調製乳
WO2021053636A1 (en) * 2019-09-20 2021-03-25 Sofar S.P.A. Bacterial strains, their compositions and their use for the treatment of gastrointestinal disorders

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DIG DIS SCI, vol. Vol.56, pp.1178-1187, JPN6026012315, 2011, ISSN: 0005829426 *

Also Published As

Publication number Publication date
AU2022312760A1 (en) 2024-02-22
US20240350567A1 (en) 2024-10-24
WO2023286027A1 (en) 2023-01-19
KR20240038015A (ko) 2024-03-22
IL309883A (en) 2024-03-01
CA3222905A1 (en) 2023-01-19
IT202100018740A1 (it) 2023-01-15
CN119365205A (zh) 2025-01-24
MX2024000520A (es) 2024-01-31
EP4370142A1 (en) 2024-05-22

Similar Documents

Publication Publication Date Title
Bustamante et al. Probiotics and prebiotics potential for the care of skin, female urogenital tract, and respiratory tract
Zhao et al. Saturated long-chain fatty acid-producing bacteria contribute to enhanced colonic motility in rats
KR20230170647A (ko) 비피도박테리움 락티스 및 그 사용
JP2024525794A (ja) 新生児の治療におけるラクトバチルス・パラカゼイ（Ｌａｃｔｏｂａｃｉｌｌｕｓ ｐａｒａｃａｓｅｉ）菌株の使用
RS58549B1 (sr) Kompozicije koje sadrže bakterijski soj blautia hydrogenotrophica za upotrebu u lečenju ili prevenciji dijareje ili konstipacije
EP3986163A2 (en) Microbial compositions and methods for producing upgraded probiotic assemblages
EP4108260A1 (en) Composition for alleviating pulmonary hypertension, method for predicting prognosis of pulmonary hypertension, method for assisting in determining severity of pulmonary hypertension, and method for assisting in diagnosing pulmonary hypertension
RS62079B1 (sr) Upotreba probiotika u lečenju i/ili prevenciji atopijskog dermatitisa
Yang et al. Precise strategies for selecting probiotic bacteria in treatment of intestinal bacterial dysfunctional diseases
JP2022517754A (ja) 菌株、組成物および使用方法
KR20230131850A (ko) 아동의 성장 및 사회 기능을 향상시키기 위한 프로바이오틱스조성물 및 이의 사용 방법
Zhang et al. Lactiplantibacillus plantarum ST-III-fermented milk improves autistic-like behaviors in valproic acid-induced autism spectrum disorder mice by altering gut microbiota
US20240226191A1 (en) Compositions and methods for treating disease
CN114728028A (zh) 包括具有增强的持久性的新微生物的组合物、新微生物和益生元的协同组合
EP4251183A1 (en) Methods of preventing, delaying or ameliorating atopic diseases
US20250170194A1 (en) Microbial compositions and methods for producing upgraded probiotic assemblages
US11850270B2 (en) Probiotics and methods of use
JPWO2023286027A5 (https=)
JP2023012558A (ja) 腸内細菌叢構成比率調整剤
EA053058B1 (ru) Применение бактериальных штаммов lactobacillus paracasei для лечения новорожденных
Shan et al. 3′-Sialyllactose ameliorates antibiotic-associated diarrhea by shaping unique gut microbiota and metabolite composition
KR20220118423A (ko) 박테리아 균주를 포함하는 조성물
Noguera Human gut microbiome metabolism and autism spectrum disorder
DK202430232A1 (en) Nutritional composition comprising bifidobacterium bifidum r0071 and human milk oligosaccharides
WO2025219497A1 (en) Combination comprising bifidobacterium bifidum ha-132 and human milk oligosaccharides

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20240115

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A525

Effective date: 20240312

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250627

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250627

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20260325

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260331